Snapshots of ARF1 Implications for Mechanisms of Activation and Inactivation by Roth, Michael G
Cell, Vol. 97, 149±152, April 16, 1999, Copyright 1999 by Cell Press
Snapshots of ARF1: Minireview
Implications for Mechanisms
of Activation and Inactivation
of S. cerevisiae and each of the six mammalian ARFs
can complement the deletion of the two yeast genes.
ARF1 was discovered to be a component of the coat
found on vesicles produced from isolated Golgi mem-
branes and was subsequently found to be necessary to
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form those vesicles, called COPI vesicles, in vitro (see
Rothman and Wieland, 1996 and references therein).
ARF1 was also later found to be required to formUsually by the time enough pure protein is available to
clathrin-coated vesicles containing AP1 or AP3 adaptorgrow crystals and solve a structure, biochemical experi-
complexes at the trans-Golgi network (TGN) and on en-ments have produced sufficient data to allow hypothe-
dosomes (Stamnes and Rothman, 1993; Ooi et al., 1998).ses to be formulated and models of protein function to
The role for ARF1 for regulating vesicle traffic in vivobe proposed. The atomic structure then becomes the
was confirmed by expressing in intact cells mutants ofbest test of aspects of an existing model. Often, the
ARF1 that were defective in either GTP binding or GTPstructure confirms in an elegant way what we thought we
hydrolysis. The mutant defective in binding GTP pre-already knew. Occasionally, the structure of a protein, or
vented coat proteins from binding to the Golgi, resultingcomplex of proteins, is incompatible with preconceived
in the migration of Golgi membranes back to the endo-ideas and forces an existing model to be modified. In
plasmic reticulum (ER), a phenotype similar to that ob-rare cases, the structure is so unexpected that it requires
served in cells treated with brefeldin A (see review bya complete reevaluation of preexisting data. In two re-
Chardin and McCormick, this issue of Cell). The mutantcent papers in Cell, Jonathan Goldberg has provided
defective in GTP hydrolysis caused COPI proteins to
us with the structures of the small GTPase, ADP-ribosy-
bind irreversibly to membranes and to prevent subse-
lation factor 1 (ARF1), in complexes with important regu-
quent delivery of vesicles into the Golgi (reviewed by
lators: the exchange domain that activates ARF1, and
Rothman and Wieland, 1996; Schekman and Orci, 1996).
the GTPase-activating protein (GAP) domain that inacti-
Although there is some evidence for a role for COPI
vates it (Goldberg, 1998, 1999). The first structure sup-
vesicles in anterograde transport between the ER and
ports previous biochemical studies that raised ques- Golgi, it is clear that COPI vesicles are required for retro-
tions about the ability of the ARF1 exchange protein to grade transport between the Golgi and the ER (reviewed
control where ARF1 binds to membranes (Franco et al., by Springer et al., 1999). For the control of COPI vesicle
1996; Antonny et al., 1997; Paris et al., 1997). The second formation, ARF1 operates as a binary switch, active
structure indicates that the ARF1 GTPase activating pro- when bound to GTP and inactive when bound to GDP.
tein (ARF GAP) functions differently from previously The Prevailing Model of Activation of ARF
studied GAPs (Scheffzek et al., 1998). Taken together, When bound to GDP, ARF1 is found in the cytosol. ARF1
these new data suggest that the mechanisms by which binds GDP with high affinity and in order to become
ARF controls vesicle coat formation are more compli- active must interact with guanine nucleotide exchange
cated than previously was imagined. factors (GEFs) that stimulate the exchange of the GDP
ARF Proteins on ARF for GTP in the cytosol. ARFs are myristoylated
ARFs belong to the superfamily of small GTPases re- at the amino terminus and tight membrane binding by
lated to Ras (Moss and Vaughan, 1998). There are six ARF requires that the myristate insert into the lipid bi-
ARF proteins identified in mammalian cells, and two in layer. Since ARF1 is an abundant protein found through-
S. cerevisiae. The mammalian ARFs fall into three out the cytosol, and the coat proteins regulated by ARF1
classes by sequence comparison. Class I ARFs (ARF1± must form only at certain membrane locations, it was
ARF3) are the best studied and appear to be functionally proposed that the site of ARF1 activity is determined
redundant. These proteins control the formation of at by the location of the GEF responsible for the release
least three different vesicle coats that act at distinct of GDP from ARF. Originally it was imagined that the
steps in intracellular membrane transport. Vesicle coats ARF GEF would be a transmembrane protein located on
are thought to collect cargo proteins and to impart the Golgi membranes, similar to the transmembrane protein,
curvature to lipid bilayers necessary for pinching off Sec12p, that acts at the ER as the GEF for the small
membrane vesicles (see Springer et al., this issue of GTPase, Sar1p. Sar1p regulates formation of COPII vesi-
Cell, for a review of vesicle formation). The function of cles that are responsible for anterograde transport be-
the class II ARFs, ARF4 and ARF5, is not known. ARF6 tween the ER and the Golgi (reviewed by Springer et al.,
(class III) is found at the plasma membrane and regulates 1999). It was imagined that the ARF GEF would recruit
ARF-GDP from the cytosol and stimulate the releasein some way either membrane traffic or cytoskeleton
of the GDP. GTP would bind in its place, inducing aorganization, or perhaps both. The two yeast ARFs are
conformational change that would cause the myristoy-functionally redundant and are required for maintenance
lated amino terminus of ARF to insert into the nearbyof the organization of secretory and endocytic path-
membrane. In this way, activated ARF would be deliv-ways. ARF activity is necessary for vegetative growth
ered to the correct membrane.
However, subsequent experimental data have raised
several questions about this simple, straightforward* E-mail: michael.roth@email.swmed.edu.
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Figure 1. Structure of ARF1 in the Triphos-
phate Conformation
Please see text for details. The figure was
kindly provided by Jonathan Goldberg.
model. Seven proteins capable of stimulating guanine translate 7 AÊ parallel to the sheet, pushing loop l3 into
the space that was the binding pocket for the aminonucleotide exchange on ARF have been identified and
terminus (Figure 1B). This conformational change couldall are soluble proteins found in the cytosol. These pro-
drive the amino terminus from its binding pocket,teins are divided by sensitivity to the drug brefeldin A
allowing it to interact with membranes, or might occurinto a sensitive class, which contains the yeast proteins
only after the amino terminus has left the binding pocketSec7, Gea1, Gea2, and mammalian p200, and an insensi-
and made space for loop l3. Clues to distinguishingtive class, which contains the much smaller proteins
between these possibilities are provided by the struc-ARNO1, GRP-1, and cytohesin-1 (reviewed by Chardin
ture of nucleotide-free ARF bound to a Sec7 domain.and McCormick, 1999; Moss and Vaughan, 1998). The
For this structure, Goldberg crystallized a complex oflatter proteins each contain a pleckstrin homology do-
the 24 kDa Sec7 domain from the Gea2 protein and anmain and may associate with specific membrane sites
ARF lacking the first 17 amino acids (Goldberg, 1998).in response to the production of phosphoinositides. It
The structure presents us with a snapshot of the inter-is not known if the large GEFs can bind to specific lipids
mediate between inactive and active ARF. Most impor-and there is no information as to how they associate
tantly, it is a structure relevant to the ARF activationwith membranes.
mechanism before ARF has bound GTP. Among theThe ARF GEFs have in common a small catalytic do-
many interesting details of this structure, two stand outmain, the Sec7 domain, that is sufficient for their guanine
in their implications for the mechanism of ARF activa-nucleotide exchange activity. When the small ARF GEF,
tion. The first is that the nucleotide-free ARF in the com-ARNO1, or its isolated Sec7 domain, is reacted with
plex is in the ARF-GTP conformation. If this is not anmyristoylated ARF-GDP in vitro, it fails to catalyze nucle-
artifact of having deleted the amino terminus and itsotide exchange (Paris et al., 1997). Addition of lipid mi-
myristic acid from ARF, then this structure suggests thatcelles to the two proteins allows the exchange reaction
the conformational change that occurs on ARF that isto proceed. These observations suggest that the myris-
usually ascribed to the binding of GTP occurs beforetoylated amino terminus of ARF inhibits the exchange
GTP binds to ARF. In this model, GTP may lock ARF inreaction on ARF, unless there are lipids nearby.
its active conformation but would not be necessary toStructural Insights into the Nucleotide
stimulate formation of the active conformation. The sec-
Exchange Reaction on ARF
ond observation is, to quote Goldberg, that ªthe struc-
Two recent structures of ARF provided by Jonathan ture of ARF-GDP appears to be incompatible with the
Goldberg give insight into the mechanism of nucleotide contours of the recognition siteº of the Sec7 domain.
exchange on ARF and suggest that this reaction proba- This implies that conformational changes on ARF must
bly occurs after ARF has bound to membranes. The first precede entry of ARF into the Sec7-binding domain. In
structure, that of ARF bound to the nonhydrolyzable the case of nucleotide-free, soluble ARF lacking its first
analog GppNHp, resembles the structures of other pro- 17 amino acids, these conformational changes may oc-
teins related to Ras, particularly in the arrangement of cur spontaneously or through initial contacts with Sec7.
the switch 1 and switch 2 regions that interact with the However, biochemical data indicate that native, myris-
effectors of these proteins (Figure 1B). In contrast, the toylated ARF will not interact with Sec7 without high
switch 1 and switch 2 regions in the structure of ARF concentrations of lipids being present. Either Sec7 has
bound to GDP, which had been solved previously by a weak ability to dislodge the myristoylated amino termi-
two laboratories (Amor et al., 1994; Greasley et al., 1995), nus of ARF if there are lipids nearby to capture it, or the
do not resemble other proteins of the Ras superfamily lipids themselves begin the process by binding to the
(Figure 1A). In the GDP conformation, switch 1 of ARF amino terminus and facilitating its exit from the binding
rotates down to form strand b1 of a seven-strand b pocket (see Roth, 1999 for more details). In either case,
sheet. Loop l3 between strands b2 and b3 forms the the difference between these two mechanisms is major
base of a pocket that holds the myristoylated amino when one considers the question of how ARF is acti-
terminus (Figure 1A). When bound to GTP, switch 1 vated on the correct membrane in vivo, and needs to
be addressed experimentally.rotates up toward the active site and strands b2 and b3
Minireview
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GTPase Activation on ARF
In the prevailing model of ARF activation, once it binds
GTP and is recruited to the membrane, ARF becomes
a binding site for coat proteins, such as Golgi COPI coat
protomer (coatomer) or the AP1 clathrin adaptor. In the
most highly purified system in vitro, COPI vesicles will
form from pure lipids to which are added coatomer and
ARF-GTP-gS (Spang et al., 1998). In the purified system,
coatomer will bind to membranes that contain some
acidic lipids but will not form vesicles in absence of
activated ARF. ARF must therefore be able to bind coat-
omer and arrange it in some way that curves mem-
branes. Once bound to GTP, the intrinsic rate of GTP
hydrolysis on ARF is exceedingly slow. Since either mu-
tants of ARF that fail to hydrolyze GTP or nonhydrolyz-
able analogs of GTP inhibit secretion when added to
cells, it was logical to conclude that a GTPase-activating
reaction must occur in vivo to allow coat proteins to
disassemble and ARF to recycle back to the ground
state. In vitro experiments for producing vesicles indi-
cated that a GAP protein was not necessary before vesi-
cle budding, suggesting that the GAP reaction would
be a late event and occur after the vesicle had budded
(Ostermann et al., 1993; Spang et al., 1998). However,
several simple predictions of this model have not been
observed. Although COPI vesicles are commonly iso-
lated after they are made with GTP-gS, published gradi-
ent profiles of purified COPI vesicles do not contain a
major polypeptide migrating with the apparent molecu-
lar weight of ARF GAP (Serafini et al., 1991a, 1991b).
This suggests that the interaction between ARF GAP
and activated ARF is not stable. In addition, when the
first ARF GAP was identified, it was found to bind to
Figure 2. Structure of the ARF1±ARF GAP Complex
Golgi membranes in a manner acutely sensitive to brefel-
(A) Ribbon diagram of human ARF1 bound to the catalytic domain
din A, similar to ARF and COPI. This suggested that the of rat ARF-GAP.
GAP might enter the vesicle on the Golgi before the (B) The complex is rotated 908 about the vertical axis.
budding step. Finally, for both COPI coats and clathrin/ (Reprinted from Goldberg, 1999.)
AP1 coats, vesicles can be made in vitro with ARF-
GTP under conditions where the vesicles isolated do
not contain detectable ARF (Ktistakis et al., 1996; Zhu et the GAP protein, usually including an arginine, that ex-
al., 1998; but see Stamnes et al., 1998 for an alternative tend into the nucleotide-binding pocket of the G protein
explanation). One interpretation of these results is that (Tesmer et al., 1997; Scheffzek et al., 1998). In contrast,
the GAP reaction on ARF might occur early, before vesi- the GAP-binding site on ARF does not overlap with its
cles had budded (see also Springer et al., 1999). effector-binding site, nor does ARF GAP supply any
Structure of the Complex of ARF-GDP residues to the active site that could be involved in
and a GAP Domain hydrolysis (Figure 2). The major direct contribution of
The minimum domain of rat p47 ARF GAP containing ARF GAP to the hydrolysis reaction appears to be
GAP activity for ARF is approximately 130 N-terminal through stabilizing the switch 2 region of ARF to align
amino acids that contain the zinc finger motif that is a glutamine 71 to participate in the hydrolysis reaction.
signature for ARF GAP proteins (Cukierman et al., 1995). With all of these differences from the standard mecha-
In a recent article in Cell, Goldberg (1999) has provided nism by which GAP proteins act on small G proteins,
us with the crystal structure of ARF-GDP bound to the how then does ARF GAP accelerate GTP hydrolysis?
130±amino acid GAP catalytic domain. This structure When coatomer is added to ARF-GTP and the GAP,
represents the product complex of the GTPase reaction the GTPase reaction in vitro is accelerated 1000-fold
and so only inferences can be drawn about the active (Goldberg, 1999). One simple mechanism for this rate
site alignment in the transition state where hydrolysis enhancement is for coatomer to provide the residues
would occur. The structure is remarkable and unlike the that enter the active site and accelerate hydrolysis. It is
complexes between other GAP proteins and G proteins possible that it is the complex of coatomer and ARF
large or small. For other Ras-related proteins, the GAP- that is recognized by the GAP, leading to an orderly
binding domain overlaps the effector-binding site, pre- sequence of events compatible with prevailing ideas of
cluding simultaneous interactions between the GTP- the role of ARF GAP. However, if the interaction of GAP
binding protein, effector, and GAP. In those proteins, with ARF leads to a slow rate of hydrolysis, there is no
reason a priori to propose that the GAP interaction withthe hydrolysis reaction is accelerated by residues from
Cell
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Springer, S., Spang, S., and Schekman, R. (1999). Cell 97, this issue,ARF must follow the coatomer interaction. Another pos-
145±148.sibility is that the GAP interacts with ARF earlier than
Stamnes, M.A., and Rothman, J.E. (1993). Cell 73, 999±1005.coatomer, and that the complex of ARF and GAP pro-
Stamnes, M., Schiavo, G., Stenbeck, G., Sollner, T.H., and Rothman,vides the binding site for the coat proteins (see also Zhu
J.E. (1998). Proc. Natl. Acad. Sci. USA 95, 13676±13680.et al., 1998 and Springer et al., 1999). Once the coat
Tesmer, J.J.G., Berman, D.M., Gilman, A.G., and Sprang, S.R. (1997).has formed and become stable (through interlocking
Cell 89, 251±261.subunits perhaps) ARF might hydrolyze GTP and both
Zhu, Y.X., Traub, L.M., and Kornfeld, S. (1998). Mol. Biol. Cell 9,ARF and GAP might leave the coat, possibly to recycle
1323±1337.for more rounds of coatomer addition.
Rather than merely confirming what we thought that
we knew, the snapshots of ARF provided to us by Gold-
berg challenge our ideas of how ARF works. Clearly
structures of additional complexes in the pathway of
ARF action will provide major insight into its mechanism.
One of these will certainly be the trimeric complex of
ARF, ARF GAP, and coatomer subunits. Others will re-
quire that the major technical hurdle of the insolubility of
myristoylated full-length ARF is solved, so that, among
other things, we might learn how nucleotide hydrolysis
on ARF can be coupled to extraction of the amino termi-
nus of ARF from the membrane. The uniqueness of the
ARF exchange and GAP reactions in relation to those
that have been studied with other G proteins reflects
the fact that the membrane is also a player in the cycle
of ARF activation and inactivation (Goldberg, 1998). Why
this is the case, and why ARF is myristoylated whereas
Sar1p, a small G protein with a similar function, is not,
remain major questions for the future.
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